Dolasetron Mesylate

CAS 115956-13-3 4 FDA-DMF suppliersSmall Molecule

Overview

Dolasetron Mesylate is a serotonin 5-HT3 receptor antagonist used to prevent nausea and vomiting caused by cancer chemotherapy and surgery. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.

API suppliers (1)

Suppliers of Dolasetron Mesylate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • ROLABO OUTSOURCING SL

Therapeutic areas

GastroenterologyOncologyAnesthesiology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.